Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2012

View Archived Issues

Phase III trial compares antibiotics in children with neglected tropical disease

Study links gene's methylation status to response of colorectal cancer to chemotherapy

Sustained T-cell responses obtained with HCV vaccine based on rare adenoviral vectors

Novel dual specificity protein kinase TTK inhibitors reported

XiberScience identifies new RhoA-inhibiting peptides

Novel PET imaging agent described for use in breast cancer diagnosis

Medivir designs new cathepsin S inhibitors

Stem Cell Educator therapy evaluated in patients with type 1 diabetes

Chinese company patents novel PPAR agonists

Pfizer presents new glucokinase activators

Otsuka Pharmaceutical and UCB adjust focus of collaboration

Otsuka Pharmaceutical files NDA in Japan

First study site chosen for pivotal phase II/III trial in hemophilia

Treatment begins in phase II study of Advaxis' ADXS-HPV

Spherix completes SPX-106 toxicology study for IND submission

Fifth Merrimack Pharmaceuticals program advances to clinic

World's first hepatitis E vaccine approved in China

Fostoin set for launch in Japan

Health Canada grants priority review status to Cinryze

Phytopharm reports preclinical data on Cogane in ALS

Astex Pharmaceuticals transfers results of epigenetics project to GSK

Nuron Biotech licenses flu vaccine to Mitsubishi Tanabe Pharma for Japan

Photocure completes enrollment in phase IIb trial of Visonac

Sobi signs licensing agreement for therapy for neonates with diuresis and seizures

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...